HIGHLIGHTS   |  March 10, 2020   Analysis Reveals Ideal Time Period to Begin Adjuvant Chemotherapy for HER2-Positive Breast Cancer The study found that 31 to 60 days seems to be the ideal time period to begin adjuvant chemotherapy in HER2-positive breast cancer patients. Read more   Individualizing Early-Stage HER2-Positive Breast Cancer As more agents become approved, it’s important to individualize therapy for this patient population, Sara A. Hurvitz, MD, said at the 37th Annual Miami Breast Cancer Conference. Read more ADVERTISEMENT